NewGenIvf Group Limited(NIVFW)Earnings, Financials & Key Ratios
NIVFW•NASDAQ
$0.04
0.0× P/E·Price updated Jun 27, 2026
AboutNewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.Show more
- Revenue$5M-13.0%
- EBITDA-$10M-972.3%
- Net Income$10M+1981.8%
- EPS (Diluted)16.80+175.3%
- Gross Margin20.22%-39.9%
- EBITDA Margin-216.38%-1132.6%
- Operating Margin-226.95%-962.9%
- Net Margin209.02%+2263.1%
- ROE80.63%+235.4%
NIVFW Price & Volume
NewGenIvf Group Limited (NIVFW) stock price & volume — 10-year historical chart
Loading chart...
Severe Capital Erosion Threatens Clinical Operational Viability
Investment Thesis • Updated 2024Q4
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity insolvency risk
"NewGenIvf Group faces an existential crisis characterized by a rapid contraction in total assets from $70.8M in 2022Q4 to $3.8M in 2024Q4, signaling a fundamental breakdown in its reproductive tourism business model. The company's reliance on regulatory arbitrage in volatile markets, combined with a negative equity position of -$844.6K, suggests that the firm lacks the necessary capital buffer to sustain its high-cost clinical infrastructure. Investors should monitor the company's inability to generate positive free cash flow, which reached a burn of -$6.4M in 2024Q4, as a primary indicator of imminent insolvency risk."
Verdict Logic
the company's precarious liquidity position, highlighted by cash reserves of only $457.7K against $5.1M in total liabilities, presents an unacceptable risk of insolvency.
NIVFW Growth Metrics
NewGenIvf Group Limited (NIVFW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-7.36%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years178.23%
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-35.47%
TTM-
Return on Capital
10 Years-66.49%
5 Years-66.49%
3 Years-40.47%
Last Year-68.73%
Peers Comparison
Key metrics vs top competitors for NewGenIvf Group Limited (NIVFW)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.04 | $20.59K | 0.00 | -13.01% | 209.02% | 80.63% | — | |
| $4.46 | $289.33M | -4.80 | 1.59% | -29.44% | -69.5% | — | |
| $15.43 | $1.76B | -12.65 | 8.28% | -25.66% | -50.82% | — | |
| $28.51 | $2.23B | 43.86 | 10.4% | 5.23% | 13.34% | — | |
| $13.22 | $427.44M | -4.51 | -21.56% | -9.84% | -27.1% | — | |
| $18.76 | $1.46B | -2.79 | 1.53% | -30.15% | -47.65% | — |
Compare NIVFW vs Peers
NewGenIvf Group Limited (NIVFW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when NIVFW posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NIVFW Frequently Asked Questions
NewGenIvf Group Limited (NIVFW) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is NewGenIvf Group Limited's revenue?
NewGenIvf Group Limited (NIVFW) reported $2.8M in revenue for fiscal year 2025. This represents a 32% decrease from $4.1M in 2021.
How fast is NewGenIvf Group Limited growing?
NewGenIvf Group Limited (NIVFW) saw revenue decline by 13.0% over the past year.
Is NIVFW profitable?
NewGenIvf Group Limited (NIVFW) reported a net loss of $0.5M for fiscal year 2025.
Dividend & Returns
What is NIVFW's return on equity?
NewGenIvf Group Limited (NIVFW) has a return on equity (ROE) of 80.6%. This is excellent, indicating efficient use of shareholder capital.
What is NewGenIvf Group Limited's free cash flow?
NewGenIvf Group Limited (NIVFW) had negative free cash flow of $6.7M in fiscal year 2025, likely due to heavy capital investments.